Multitasking by multivalent circular DNA aptamers
- PMID: 16482500
- DOI: 10.1002/cbic.200500316
Multitasking by multivalent circular DNA aptamers
Abstract
Nucleic acid aptamers are finding increasing applications in biology, especially as therapeutic candidates and diagnostic components. An important characteristic in meeting the needs of these applications is improved stability in physiological fluids, which is most often accomplished with chemical modification or unnatural nucleotides. In an alternative approach we have specified the design of a multivalent circular DNA aptamer topology that encompasses a number of properties relevant to nucleic acid therapeutic candidates, especially the ability to multitask by combining different activities together within a modular structure. Improved stability in blood products, greater conformational stability, antidoting by complementary circular antiaptamers, heterovalency, transcription factor decoy activity and minimal unintended effects upon the cellular innate immune response are desirable properties that are described here. Multitasking by circular DNA aptamers could similarly find applications in diagnostics and biomaterials, where the combination of interchangeable modules might generate new functions, such as anticoagulation coupled with reversible cell capture as, described here. These results provide a platform for further exploration of multivalent circular aptamer properties, especially in novel combinations of nucleic acid therapeutic modes.
Similar articles
-
In vitro and in vivo production and purification of circular RNA aptamer.J Biotechnol. 2009 Feb 23;139(4):265-72. doi: 10.1016/j.jbiotec.2008.12.012. Epub 2008 Dec 25. J Biotechnol. 2009. PMID: 19138712
-
Cancer cell targeting using multiple aptamers conjugated on nanorods.Anal Chem. 2008 Feb 1;80(3):567-72. doi: 10.1021/ac702322j. Epub 2008 Jan 1. Anal Chem. 2008. PMID: 18166023
-
Evolution of a highly functional circular DNA aptamer in serum.Nucleic Acids Res. 2020 Nov 4;48(19):10680-10690. doi: 10.1093/nar/gkaa800. Nucleic Acids Res. 2020. PMID: 33021630 Free PMC article.
-
Nucleic acid aptamers as adjuncts to vaccine development.Curr Opin Mol Ther. 2006 Apr;8(2):122-9. Curr Opin Mol Ther. 2006. PMID: 16610764 Review.
-
Nanotechnology and aptamers: applications in drug delivery.Trends Biotechnol. 2008 Aug;26(8):442-9. doi: 10.1016/j.tibtech.2008.04.006. Epub 2008 Jun 19. Trends Biotechnol. 2008. PMID: 18571753 Review.
Cited by
-
CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade.Mol Ther Nucleic Acids. 2022 Jan 19;27:998-1009. doi: 10.1016/j.omtn.2022.01.010. eCollection 2022 Mar 8. Mol Ther Nucleic Acids. 2022. PMID: 35228895 Free PMC article.
-
Aptamers: problems, solutions and prospects.Acta Naturae. 2013 Oct;5(4):34-43. Acta Naturae. 2013. PMID: 24455181 Free PMC article.
-
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition.Molecules. 2020 Nov 10;25(22):5227. doi: 10.3390/molecules25225227. Molecules. 2020. PMID: 33182593 Free PMC article. Review.
-
Enrichment of cancer cells using aptamers immobilized on a microfluidic channel.Anal Chem. 2009 Feb 1;81(3):1033-9. doi: 10.1021/ac802092j. Anal Chem. 2009. PMID: 19115856 Free PMC article.
-
Circular and linear: a tale of aptamer selection for the activation of SIRT1 to induce death in cancer cells.RSC Adv. 2020 Dec 21;10(73):45008-45018. doi: 10.1039/d0ra07857c. eCollection 2020 Dec 17. RSC Adv. 2020. PMID: 35516259 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources